Mid-infrared spectral technology has shown a high degree of promise in detecting glucose in plasma. OptiScan Biomedical has developed a glucose monitor based on mid-infrared spectroscopy that withdraws blood samples and measures plasma glucose. The objective of this study was to evaluate the accuracy and performance of the OptiScanner™ 5000 system on different pools of blood.
Evaluation of the performance of a new OptiScanner™ 5000 system for an intermittent glucose monitoring / A. Barassi, M. Umbrello, F. Ghilardi, C.A.L. Damele, L. Massaccesi, G. Iapichino, G.V. Melzi d'Eril. - In: CLINICA CHIMICA ACTA. - ISSN 0009-8981. - 438(2015 Jan 01), pp. 252-254.
Evaluation of the performance of a new OptiScanner™ 5000 system for an intermittent glucose monitoring
A. BarassiPrimo
;M. UmbrelloSecondo
;C.A.L. Damele;L. Massaccesi;G. IapichinoPenultimo
;G.V. Melzi d'ErilUltimo
2015
Abstract
Mid-infrared spectral technology has shown a high degree of promise in detecting glucose in plasma. OptiScan Biomedical has developed a glucose monitor based on mid-infrared spectroscopy that withdraws blood samples and measures plasma glucose. The objective of this study was to evaluate the accuracy and performance of the OptiScanner™ 5000 system on different pools of blood.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Evaluation of the performance of a new OptiScanner.pdf
accesso riservato
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
615.51 kB
Formato
Adobe PDF
|
615.51 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
